Health care stocks were flat to lower pre-bell Wednesday as the iShares Biotechnology ETF (IBB) was unchanged and the Health Care Select Sector SPDR Fund (XLV) was down 0.5% recently.
Medtronic (MDT) shares were up 0.5% after the company reported higher fiscal Q4 non-GAAP earnings and net sales.
Moderna (MRNA) said it has voluntarily withdrawn its Biologics License Application for mRNA-1083, its flu and COVID combination vaccine candidate for adults aged 50 and older. Shares of Moderna were more than 1% higher premarket.
Belite Bio (BLTE) shares were up 0.4% after the company said the US Food and Drug Administration granted breakthrough therapy designation to its Tinlarebant drug for treating Stargardt disease.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。